Molecular Partners AG
MLLCF
$4.01
$0.215.53%
OTC PK
| 06/30/2026 | 03/31/2026 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | 0.58% | 15.39% | |||
| Gross Profit | -0.58% | -15.39% | |||
| SG&A Expenses | -1.57% | -10.81% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -0.06% | 6.12% | |||
| Operating Income | 0.06% | -6.12% | |||
| Income Before Tax | -1.99% | -3.93% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -1.99% | -3.90% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -1.99% | -3.90% | |||
| EBIT | 0.06% | -6.12% | |||
| EBITDA | -0.11% | -4.01% | |||
| EPS Basic | 0.14% | -3.64% | |||
| Normalized Basic EPS | 0.18% | -3.35% | |||
| EPS Diluted | 0.14% | -3.64% | |||
| Normalized Diluted EPS | 0.18% | -3.35% | |||
| Average Basic Shares Outstanding | 2.14% | 0.24% | |||
| Average Diluted Shares Outstanding | 2.14% | 0.24% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||